A detailed history of Exodus Point Capital Management, LP transactions in Inogen Inc stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 37,103 shares of INGN stock, worth $388,468. This represents 0.0% of its overall portfolio holdings.

Number of Shares
37,103
Holding current value
$388,468
% of portfolio
0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$7.67 - $12.98 $284,580 - $481,596
37,103 New
37,103 $360,000
Q1 2024

May 14, 2024

SELL
$5.26 - $10.15 $1.21 Million - $2.34 Million
-230,264 Reduced 28.78%
569,743 $4.6 Million
Q3 2023

Nov 09, 2023

BUY
$5.14 - $11.28 $3.36 Million - $7.37 Million
653,604 Added 446.44%
800,007 $4.18 Million
Q2 2023

Aug 10, 2023

BUY
$10.01 - $13.86 $55,515 - $76,867
5,546 Added 3.94%
146,403 $1.69 Million
Q1 2023

May 11, 2023

BUY
$11.88 - $26.0 $1.67 Million - $3.66 Million
140,857 New
140,857 $1.76 Million
Q3 2022

Nov 10, 2022

BUY
$22.74 - $31.8 $243,317 - $340,260
10,700 New
10,700 $260,000
Q3 2021

Nov 15, 2021

SELL
$43.09 - $82.26 $834,954 - $1.59 Million
-19,377 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$52.03 - $68.77 $1.01 Million - $1.33 Million
19,377 New
19,377 $1.26 Million
Q1 2021

May 17, 2021

SELL
$43.96 - $55.99 $412,168 - $524,962
-9,376 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$27.19 - $44.68 $254,933 - $418,919
9,376 New
9,376 $419,000
Q3 2020

Nov 16, 2020

SELL
$27.01 - $37.31 $378,140 - $522,340
-14,000 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$32.85 - $53.77 $459,900 - $752,780
14,000 New
14,000 $497,000
Q1 2020

May 15, 2020

SELL
$32.63 - $67.59 $237,056 - $491,041
-7,265 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$45.95 - $76.15 $333,826 - $553,229
7,265 New
7,265 $496,000

Others Institutions Holding INGN

About Inogen Inc


  • Ticker INGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 22,866,500
  • Market Cap $239M
  • Description
  • Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respirat...
More about INGN
Track This Portfolio

Track Exodus Point Capital Management, LP Portfolio

Follow Exodus Point Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Exodus Point Capital Management, LP with notifications on news.